Terms: = Leukemia AND MLLT4, ENSG00000130396, 4301 AND Treatment
4 results:
1. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
[TBL] [Abstract] [Full Text] [Related]
2. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
[TBL] [Abstract] [Full Text] [Related]
3. Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse.
Higuchi Y; Tokunaga K; Watanabe Y; Kawakita T; Harada N; Yamaguchi S; Nosaka K; Mitsuya H; Asou N
Cancer Genet; 2016 Jun; 209(6):267-71. PubMed ID: 27268298
[TBL] [Abstract] [Full Text] [Related]
4. [Bioinformatic analysis of chronic myeloid leukemia progression and preliminary experimental verification].
Zhang JF; Liu XL; Lin YD; Pan JW; Xu N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):909-13. PubMed ID: 25130802
[TBL] [Abstract] [Full Text] [Related]
